Sunflower Bank N.A. Has $267,000 Position in MetLife, Inc. $MET

Sunflower Bank N.A. reduced its stake in MetLife, Inc. (NYSE:METFree Report) by 10.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,315 shares of the financial services provider’s stock after selling 392 shares during the period. Sunflower Bank N.A.’s holdings in MetLife were worth $267,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the stock. Sivia Capital Partners LLC acquired a new stake in shares of MetLife in the 2nd quarter valued at approximately $404,000. Chesley Taft & Associates LLC boosted its stake in shares of MetLife by 6.3% in the 2nd quarter. Chesley Taft & Associates LLC now owns 20,227 shares of the financial services provider’s stock valued at $1,627,000 after purchasing an additional 1,199 shares in the last quarter. Graves Light Lenhart Wealth Inc. boosted its position in MetLife by 15.2% during the 2nd quarter. Graves Light Lenhart Wealth Inc. now owns 4,859 shares of the financial services provider’s stock worth $391,000 after buying an additional 641 shares during the period. Westbourne Investments Inc. boosted its position in MetLife by 176.3% during the 2nd quarter. Westbourne Investments Inc. now owns 13,375 shares of the financial services provider’s stock worth $1,076,000 after buying an additional 8,535 shares during the period. Finally, Balefire LLC acquired a new stake in MetLife during the 2nd quarter worth approximately $267,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Performance

Shares of MET stock opened at $78.71 on Thursday. The firm has a market capitalization of $52.34 billion, a PE ratio of 13.34, a price-to-earnings-growth ratio of 0.71 and a beta of 0.87. The firm has a fifty day simple moving average of $78.26 and a two-hundred day simple moving average of $78.21. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter last year, the firm posted $2.28 EPS. Analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th were paid a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date was Tuesday, August 5th. MetLife’s payout ratio is 38.47%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on MET. Wolfe Research upgraded shares of MetLife to a “strong-buy” rating in a research report on Tuesday. Wall Street Zen downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Cowen reiterated a “buy” rating on shares of MetLife in a research report on Friday, August 22nd. Jefferies Financial Group lifted their target price on shares of MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a research report on Monday, August 11th. Finally, Keefe, Bruyette & Woods dropped their price target on shares of MetLife from $94.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $95.55.

Read Our Latest Research Report on MetLife

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.